Dr. Reddy’s Labs has launched a generic drug for treating high blood pressure, the company said Thursday.

APP Pharmaceuticals has received regulatory approval for the treatment of a complication related to hypothyroidism.

The Food and Drug Administration has approved a drug made by Novartis for treating chronic obstructive pulmonary disease, the FDA said Friday.

Santal Solutions last week announced its dietary supplement Assurance Blood Health Support has gained distribution through Rite Aid and Walgreens.

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating deep vein thrombosis in patients undergoing knee or hip replacement surgery, a J&J subsidiary said Friday.

Prestige Brands recently extended its Luden’s throat drop brand with Luden’s orange supplement drops, a vitamin-enriched product with 100% of the recommended daily value of vitamin C.

In an effort to help those suffering from acne, La Roche-Posay has introduced its new Effaclar K Daily Renovating Anti-Relapse Acne Treatment 1, a daily treatment to address the ongoing, recurring life cycle of acne.

The Food and Drug Administration has accepted a regulatory approval application for a drug designed to prevent premature birth in pregnant women.

Lelo on Thursday launched Intimina by Lelo, a new brand of intimate wellness products positioned as a premium to what’s on the shelf today.

Xlear recently announced the release of two new products: Xlear nasal spray and Kids Xlear nasal spray.

Generic drug maker Dr. Reddy’s Labs has launched its version of a popular antibiotic.

The Food and Drug Administration has approved a medication designed to treat acute and chronic moderate to severe pain, where the use of an opioid analgesic is suitable.